Magnitude and factors associated with lost to follow-up among women under option B+ PMTCT program at East Wollega public health facilities, western Ethiopia

• Главные авторы: Tadesse Tolossa (Автор), Diriba Mulisa (Автор), Getahun Fetensa (Автор), Ginenus Fekadu (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2020-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: An initiation of lifelong antiretroviral therapy to pregnant and lactating women living with Human immune virus (HIV) without eligibility criteria is Option B+ Prevention of Mother to Child Transmission (PMTCT). However, loss to follow-up from the PMTCT creates a great obstacle for the s...